{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:15:46Z","timestamp":1720566946522},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001849","name":"Defence Research & Development Organization","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","jocn-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jocn.2017.04.019","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T09:45:58Z","timestamp":1495100758000},"page":"82-88","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Influence of perfluorocarbons on Carbamazepine and Benzodiazepine for a neuro-lung protective strategy"],"prefix":"10.1016","volume":"43","author":[{"given":"V.","family":"Natchimuthu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabu","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murugan","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2017.04.019_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1528-1157.44.s4.3.x","article-title":"Newer antiepileptic drugs and cognitive issues","volume":"44","author":"Aldenkamp","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2017.04.019_b0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/bmj.318.7176.106","article-title":"Drug treatment of epilepsy","volume":"318","author":"Feely","year":"1999","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.jocn.2017.04.019_b0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/1059-1311(92)90037-2","article-title":"Therapeutic drug monitoring improves seizure control and reduces anti-convulsant side effects in patients with refractory epilepsy","volume":"1","author":"McKee","year":"1992","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2017.04.019_b0020","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/08830738030180060501","article-title":"Relative influence of epileptic seizures and of epilepsy syndrome on cognitive function","volume":"18","author":"Tomp","year":"2003","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.jocn.2017.04.019_b0025","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jocn.2013.09.022","article-title":"Effect of anti-epileptic drug therapy on the unborn child","volume":"21","author":"Vajda","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2017.04.019_b0030","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.bmc.2013.05.031","article-title":"Design, synthesis and evaluation of novel 2-hydroxy pyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors","volume":"21","author":"Addla","year":"2013","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"10.1016\/j.jocn.2017.04.019_b0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/11530220-000000000-00000","article-title":"Medical management of Lennox-Gastaut syndrome","volume":"24","author":"Michoulas","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jocn.2017.04.019_b0040","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1166\/jnsne.2013.1088","article-title":"Targeted delivery of 4-aminopyridine into the rat brain by minicontainers from carbon-nanodiamonds composite","volume":"2","author":"Volnova","year":"2013","journal-title":"J Neurosci Neuroeng"},{"issue":"2","key":"10.1016\/j.jocn.2017.04.019_b0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2012.10.018","article-title":"Advantages and limitations of brain imaging methods in the research of absence epilepsy in humans and animal models","volume":"3212","author":"Lenkov","year":"2013","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jocn.2017.04.019_b0050","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0b013e31822cfcd6","article-title":"Cognition and epilepsy","volume":"77","author":"Meador","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jocn.2017.04.019_b0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00023210-199810030-00003","article-title":"Treatment of Lennox-Gastaut syndrome","volume":"10","author":"Delanty","year":"1998","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.jocn.2017.04.019_b0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/11599020-000000000-00000","article-title":"GABAA receptor physiology and its relationship to the mechanism of action of the 1,5-Benzodiazepine Clobazam","volume":"26","author":"Sankar","year":"2012","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.jocn.2017.04.019_b0065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3171\/jns.2005.103.4.0768","article-title":"Temporal lobe epilepsy","volume":"103","author":"Ross","year":"2005","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2017.04.019_b0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2165\/00003495-200262040-00004","article-title":"Effect of antiepileptic drugs on cognitive function in individuals with epilepsy","volume":"62","author":"Brunbech","year":"2002","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.jocn.2017.04.019_b0075","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2165\/11587900-000000000-00000","article-title":"The pharmacology of new antiepileptic drugs","volume":"25","author":"Perucca","year":"2011","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.jocn.2017.04.019_b0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00023210-200418030-00001","article-title":"Treatment of partial seizures in childhood","volume":"18","author":"Coppola","year":"2004","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jocn.2017.04.019_b0085","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00023210-200317020-00003","article-title":"Stimulation of the nervous system for the management of seizures","volume":"17","author":"Jerome","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jocn.2017.04.019_b0090","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40263-013-0078-6","article-title":"Causes of CNS inflammation and potential targets for anticonvulsants","volume":"27","author":"Falip","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jocn.2017.04.019_b0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jchemneu.2015.12.007","article-title":"Fluorination of an antiepileptic drug: a self supporting transporter by oxygen enrichment mechanism","volume":"72","author":"Natchimuthu","year":"2016","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.jocn.2017.04.019_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-1139(01)00375-X","article-title":"Smart fluorine substituent effects (on bioactivity)","volume":"109","author":"Bruce","year":"2001","journal-title":"J Fluorine Chem"},{"key":"10.1016\/j.jocn.2017.04.019_b0105","first-page":"87","article-title":"Synthesis and bioactivity of 2-cyanoacrylates containing a trifluoromethylphenyl moiety","author":"Song","year":"2005","journal-title":"J Chem"},{"key":"10.1016\/j.jocn.2017.04.019_b0110","series-title":"Fluorine in bioorganic chemistry","author":"Welch","year":"1991"},{"key":"10.1016\/j.jocn.2017.04.019_b0115","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bmc.2003.12.011","volume":"12","author":"Schenck","year":"2004","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.jocn.2017.04.019_b0120","doi-asserted-by":"crossref","first-page":"23547","DOI":"10.1021\/jp0644199","article-title":"Solubilization of various fluorocarbons in a fluorinated surfactant\/water system: relation with the design of porous materials","volume":"110","author":"Belta","year":"2006","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.jocn.2017.04.019_b0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1054\/blre.1999.0113","article-title":"Perfluorinated blood substitutes and artificial oxygen carriers","volume":"13","author":"Lowe","year":"1999","journal-title":"Blood Rev"},{"key":"10.1016\/j.jocn.2017.04.019_b0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-1139(02)00200-2","article-title":"Perfluorochemical respiratory gas carriers: benefits to cell culture systems","volume":"118","author":"Lowe","year":"2002","journal-title":"J Fluorine Chem"},{"key":"10.1016\/j.jocn.2017.04.019_b0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/BIO-200046659","article-title":"Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant toin vivooxygen delivery","volume":"33","author":"Riess","year":"2005","journal-title":"Artif Cells Blood Subst. Immobil Biotechmoil"},{"key":"10.1016\/j.jocn.2017.04.019_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jfluchem.2004.09.033","article-title":"Fluorine chemistry at the millennium","volume":"126","author":"Dolbier","year":"2005","journal-title":"J. Fluorine Chem"},{"issue":"6","key":"10.1016\/j.jocn.2017.04.019_b0145","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ultrasmedbio.2006.12.007","article-title":"Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes","volume":"33","author":"Marsh","year":"2007","journal-title":"Ultrasound Med Biol"},{"issue":"4","key":"10.1016\/j.jocn.2017.04.019_b0150","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2217\/17435889.2.4.533","article-title":"Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis","volume":"2","author":"Marsh","year":"2007","journal-title":"Nanomedicine (Lond)"},{"issue":"12","key":"10.1016\/j.jocn.2017.04.019_b0155","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.ultrasmedbio.2005.07.022","article-title":"Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery","volume":"31","author":"Crowder","year":"2005","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jocn.2017.04.019_b0160","doi-asserted-by":"crossref","first-page":"10547","DOI":"10.1021\/jp204146n","article-title":"Complementary methods for the determination of dissolved oxygen content in perfluorocarbon emulsions and other solutions","volume":"115","author":"Fraker","year":"2011","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.jocn.2017.04.019_b0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.fluid.2004.07.004","article-title":"Thermodynamic properties of perfluoro-n-octane","volume":"225","author":"Dias","year":"2004","journal-title":"Fluid Phase Equilib"},{"key":"10.1016\/j.jocn.2017.04.019_b0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.fluid.2004.06.037","article-title":"Solubility of oxygen in liquid perfluorocarbons","volume":"222","author":"Dias","year":"2004","journal-title":"Fluid Phase Equilib"},{"key":"10.1016\/j.jocn.2017.04.019_b0175","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1021\/jp036225o","article-title":"SAFT modeling of the solubility of gases in perfluoroalkanes","volume":"108","author":"Dias","year":"2004","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.jocn.2017.04.019_b0180","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1021\/jp800812c","article-title":"Effective method of characterizing specific liquid fluorocarbon interactions using ultrasound","volume":"112","author":"Ravi","year":"2008","journal-title":"J Phys Chem B"},{"key":"10.1016\/j.jocn.2017.04.019_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-1139(02)00017-9","article-title":"Blood substitutes and other potential biomedical applications of fluorinated colloids","volume":"114","author":"Riess","year":"2002","journal-title":"J Fluorine Chem"},{"key":"10.1016\/j.jocn.2017.04.019_b0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9797(90)90413-I","article-title":"Deviation from molecular diffusion aging model in fluorocarbon emulsions stabilized by perfluoroalkylated surfactants","volume":"137","author":"Varescon","year":"1990","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.jocn.2017.04.019_b0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.fluid.2005.01.008","article-title":"Enzymatic method for determining oxygen solubility in perfluorocarbon emulsions","volume":"231","author":"Freire","year":"2005","journal-title":"Fluid Phase Equilib"},{"key":"10.1016\/j.jocn.2017.04.019_b0200","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jcis.2004.12.036","article-title":"Aging mechanisms of perfluorocarbon emulsions using image analysis","volume":"286","author":"Freire","year":"2005","journal-title":"J Colloid Interface Sci"},{"issue":"11","key":"10.1016\/j.jocn.2017.04.019_b0205","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1016\/j.biomaterials.2010.01.006","article-title":"Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions","volume":"31","author":"Kaneda","year":"2010","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.jocn.2017.04.019_b0210","first-page":"492","article-title":"Phase-shift, stimuli-responsive perfluorocarbon Nano droplets for drug delivery to cancer","volume":"4","author":"Rapoport","year":"2012","journal-title":"Wiley Interdisciplinary Rev: Nanomed Nanobiotechnol"},{"key":"10.1016\/j.jocn.2017.04.019_b0215","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/aps.2009.146","article-title":"Drug packaging and delivery using perfluorocarbon nanoparticles for targeted inhibition of vascular smooth muscle cells","volume":"30","author":"Zhou","year":"2009","journal-title":"Acta Pharmacol Sin"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816301849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816301849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T14:24:22Z","timestamp":1535811862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586816301849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":43,"alternative-id":["S0967586816301849"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2017.04.019","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of perfluorocarbons on Carbamazepine and Benzodiazepine for a neuro-lung protective strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2017.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}